Vol. 39 No. 5 (2022): OCTUBRE
Statement

Creation of the first national biorepository of multi-resistant bacteria available for the study of bacterial resistance in Chile

Patricia García
Pontificia Universidad Católica de Chile
Bio
Lina Rivas
Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R); GeRM Lab
Anne Peters
Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R)
Paola Henríquez
Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R)
Loriana Castillo
Hospital La Florida
Vijna Illesca
Hospital Hernán Henríquez Aravena de Temuco
Andrea Maripani
Hospital Regional Dr. Lautaro Navarro Avaria de Punta Arenas
Juan Moreno
Hospital de Iquique
Margareta Mühlhauser
Hospital DIPRECA
Lorena Porte
Clínica Alemana de Santiago
María Luisa Rioseco
Hospital de Puerto Montt
Pamela Rojas
Hospital Padre Hurtado
Francisco Silva
Hospital Clínico de la Universidad de Chile
Patricio Suazo
Hospital Regional de Talca
José M. Munita
Clínica Alemana - Universidad del Desarrollo

Published 2022-11-27

How to Cite

1.
García P, Rivas L, Peters A, Henríquez P, Castillo L, Illesca V, Maripani A, Moreno J, Mühlhauser M, Porte L, Rioseco ML, Rojas P, Silva F, Suazo P, Munita JM. Creation of the first national biorepository of multi-resistant bacteria available for the study of bacterial resistance in Chile. Rev. Chilena. Infectol. [Internet]. 2022 Nov. 27 [cited 2026 May 13];39(5). Available from: https://revinf.cl/index.php/revinf/article/view/1627

Abstract

The availability of bacterial strains for the study of bacterial resistance is key to advances in basic and clinical research. There are few biobanks of bacteria with known resistance mechanisms, isolated from clinically significant infections. A review of the literature reveals that only in the United States of America is there a biobank of resistant isolates. This publication shows the creation of the first biorepository of resistant bacteria Chile associated with the MICROB-R Laboratory Network, with the participation of 11 centers distributed throughout the country, which to date has more than 3,000 bacterial isolates studied phenotypically and genotypically, available to the Chilean scientific community